drugset
drugset / Trial / NCT03002571

Efficacy and Safety of IDP-124 Lotion for the Treatment of Moderate to Severe Atopic Dermatitis in Pediatric and Adult Subjects (301)

NCT03002571 ↗

Phase 3 Completed 338 enrolled Bausch Health Americas, Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Efficacy and Safety of IDP-124 Lotion for the Treatment of Moderate to Severe Atopic Dermatitis in Pediatric and Adult Subjects

Timeline

Start
2018-07-24
Primary completion
2020-04-14
Completion
2020-04-14

Drugs

EvaluationDrugModalityDoseRoute
Subject IDP-124 Unknown — Topical

Indications

atopic eczema